ScanPlus UK: Smart Anti-Counterfeit Solutions for Safer Public Health

1. ScanPlus U K: D elivering Sm art A nti-C ounterfeit Solutions to P rotect P ublic H ealth In today’s global pharmaceutical landscape, the proliferation of counterfeit medicines poses a significant threat to public health. These falsified drugs, often indistinguishable from genuine products, can lead to ineffective treatment, adverse reactions, and, in severe cases, fatalities. The World Health Organization estimates that counterfeit medicines account for up to 1% of sales in developed countries, representing a substantial risk to patient safety. The Challenge of Counterfeit Medicines Counterfeit medicinesinfiltrate the supply chain through various means, including unauthorized online pharmacies and complex distribution networks. These fake drugs may contain incorrect dosages, harmful ingredients, or no active ingredients at all, compromising treatment efficacy and patient trust. The European Union responded to this growing concern with the implementation of the Falsified Medicines Directive (FMD), mandating safety features like unique identifiers and anti-tampering devices on prescription medicine packaging to ensure authenticity. ScanPlus UK: A Comprehensive Solution Addressing the critical need for secure pharmaceutical supply chains, ScanPlus UK offers an advanced anti-counterfeit solution tailored for pharmaceutical manufacturers and contract manufacturing organizations (CMOs). By integrating robust serialisation processes, ScanPlus ensures that each medicine pack is uniquely identifiable and traceable throughout its journey from production to patient. Key Features and Benefits End-to-End Serialisation Management: ScanPlus provides a streamlined platform for managing serial numbers, batches, and product data, facilitating compliance with global regulations, including the EU’s FMD. Flexible Data Handling: The system supports various data formats, such as SOAP Service, CSV, and Excel, accommodating diverse operational needs and simplifying integration with existing workflows. Enhanced Collaboration: By centralizing communication between Marketing Authorisation Holders (MAHs) and CMOs, ScanPlus fosters efficient coordination, reducing errors and ensuring timely product delivery.

2. Customised Onboarding: Recognizing the unique requirements of each partner, ScanPlus offers tailored onboarding processes, ensuring seamless integration and minimal disruption to existing operations. Impact on Public Health The implementation of ScanPlus’s serialisation and anti-counterfeit measures significantly enhances the integrity of the pharmaceutical supply chain. By ensuring that only authentic medicines reach patients, the platform plays a vital role in safeguarding public health, maintaining treatment efficacy, and upholding trust in healthcare systems. Conclusion In the fight against counterfeit medicines, solutions like ScanPlus UK are indispensable. By combining advanced technology with a deep understanding of regulatory requirements, ScanPlus not only aids pharmaceutical companies in achieving compliance but also contributes to the broader goal of protecting patient health and safety. Frequently Asked Questions 1.What is pharmaceutical serialisation, and why is it important? Pharmaceutical serialisation involves assigning a unique identifier to each medicine pack, enabling tracking and verification throughout the supply chain. This process is crucial for preventing counterfeit medicines from reaching patients. 2. How does ScanPlus UK help in combating counterfeit medicines? ScanPlus UK offers a comprehensive serialisation platform that ensures each medicine pack is uniquely identifiable and traceable, aligning with global regulatory standards to prevent counterfeit infiltration. 3. What is the Falsified Medicines Directive (FMD)? The FMD is a European Union directive aimed at preventing falsified medicines from entering the legal supply chain by mandating safety features like unique identifiers and anti-tampering devices on prescription medicine packaging. 4. Who are Marketing Authorisation Holders (MAHs), and how does ScanPlus support them? MAHs are entities responsible for the marketing of a medicinal product. ScanPlus supports MAHs by providing tools for efficient serialisation management, ensuring compliance with regulatory requirements. 5. Can ScanPlus be integrated with existing systems used by CMOs? Yes, ScanPlus is designed to be flexible and can be integrated with existing systems used by Contract Manufacturing Organizations, facilitating seamless operations.

3. 6. Is ScanPlus compliant with international regulations beyond the EU? Yes, ScanPlus adheres to major global regulatory standards, including those in the US and Gulf Cooperation Council (GCC) countries, ensuring broad compliance. Post view link:- https://medium.com/@topialifesciences/scanplus-uk-delivering-smart-anti- counterfeit-solutions-to-protect-public-health-8588becb72a1